Rosacea Treatment Market Size 2022 | Worth US$ 2.51 Billion by 2027 | Growth Rate (CAGR) of 6.20% | IMARC Group

The latest research study "Rosacea Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" The global rosacea treatment market size reached US$ 1.73 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.51 Billion by 2027, exhibiting a growth rate (CAGR) of 6.20% during 2022-2027.

Rosacea treatment represents the preventive measures utilized to cure a chronic skin disease that causes redness and enlarges blood vessels. It includes topical and oral medications, such as alpha agonists, retinoids, corticosteroids, antibiotics, immunosuppressants, antihypertensive agents, etc. In severe cases, laser treatments, intense pulsed light therapies, and cosmetic surgeries are used to shrink tissues, remove thickened skin, treat rhinophyma, etc. Rosacea treatment assists in easing various symptoms, including redness, inflamed eyes, skin inflammation, puss-filled bumps that generally occur on the cheeks, chest, ear, nose, back, and forehead, etc. It also reduces skin discoloration and improves itching, blurred vision, dryness, and sensitivity to light. As a result, rosacea treatment finds wide-ranging applications in hospitals, clinics, and home care settings across the globe.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request a free sample brochure: https://www.imarcgroup.com/rosacea-treatment-market/requestsample

Rosacea Treatment Market Trends and Drivers:

Excessive temperature changes and the increasing utilization of hot drinks, spicy meals, and alcohol are among the primary factors driving the rosacea treatment market. Besides this, the escalating demand for oral therapies, such as tablets, capsules, syrups, liquids, etc., to minimize pimples, redness, bacterial inflammation, etc., is further augmenting the market growth. Moreover, the introduction of Artificial Intelligence (AI)-powered diagnostic tools that use resolutions and digital image shots in natural white light to recognize symptoms and facial lesions is also catalyzing the global market. Apart from this, the growing need for combination treatments to reduce initial prominent symptoms, prevent relapse, maintain long-term control, etc., is acting as another significant growth-inducing factor. Furthermore, the rising expenditure capacities of consumers and the inflating popularity of new generic products to increase the efficiency of the therapy are anticipated to propel the rosacea treatment market over the forecasted period.

Ask an Analyst: https://www.imarcgroup.com/request?type=report&id=6569&flag=F

Rosacea Treatment Market Report Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Bausch Health Companies Inc.
• Cellix Bio Private Limited
• Colorescience Inc.
• Croda International Plc
• Galderma S.A.
• LEO Pharma A/S
• Lupin Limited, Maruho Co. Ltd
• PruGen Pharmaceuticals
• Sol-Gel Technologies Ltd. and Timber Pharmaceuticals LLC.

The report has been segmented the market into following categories:

Breakup by Type:
• Erythematotelangiectatic Rosacea
• Papulopustular Rosacea
• Ocular Rosacea
• Phymatous Rosacea

Breakup by Drug Class:
• Antibiotics
• Alpha Agonists
• Retinoids
• Corticosteroids
• Immunosuppressants
• Antihypertensive Agents
• Others

Breakup by Route of Administration:
• Topical
• Oral

Breakup by Distribution Channel:
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• Others

Breakup by End User:
• Hospitals
• Homecare
• Specialty Clinics
• Others

Click here to view detailed information with table of content: https://www.imarcgroup.com/rosacea-treatment-market

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Reports by IMARC Group:
• https://www.imarcgroup.com/pregnancy-detection-kits-market
• https://www.imarcgroup.com/home-healthcare-market
• https://www.imarcgroup.com/blockchain-in-healthcare-market
• https://www.imarcgroup.com/pro-speakers-market
• https://www.imarcgroup.com/luxury-fashion-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.